Bryan Kobel
Chief Executive Officer presso TC BIOPHARM (HOLDINGS) PLC
Patrimonio netto: 773 $ in data 30/11/2023
Profilo
Bryan Kobel is currently the Chief Executive Officer & Director at TC Biopharm (Holdings) Plc, as well as the CEO-Biopharm North America and Chief Executive Officer at TC BioPharm (North America), Inc. He previously worked as the Managing Director at Laidlaw & Co. (UK) Ltd.
from 2012 to 2017, Managing Director at The Alberleen Group LLC from 2018 to 2020, and Head-Capital Markets at R.F.
Lafferty & Co., Inc. from 2017 to 2018.
He also served as the Head-Healthcare Investment Banking at HUTN, Inc. Mr. Kobel received his undergraduate degree from Franklin & Marshall College.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
06/02/2024 | 2 101 ( 0.22% ) | 773 $ | 30/11/2023 |
Posizioni attive di Bryan Kobel
Società | Posizione | Inizio |
---|---|---|
TC BIOPHARM (HOLDINGS) PLC | Chief Executive Officer | 01/06/2021 |
TCB Newco Ltd.
TCB Newco Ltd. Pharmaceuticals: MajorHealth Technology TCB Newco Ltd. provides clinical services. It develops CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease. The company was founded on July 5, 2021 and is headquartered in Motherwell, GB. | Corporate Officer/Principal | - |
TC BioPharm (North America), Inc. | Chief Executive Officer | 01/06/2021 |
Precedenti posizioni note di Bryan Kobel
Società | Posizione | Fine |
---|---|---|
The Alberleen Group LLC
The Alberleen Group LLC Investment Banks/BrokersFinance The Alberleen Group LLC provides investment banking services. The firm offers mergers, acquisitions advice, capital raising services, investment opportunities and merchant banking services. It serves to the energy, financials, healthcare, real estate industries. The company was founded by Jolyne Caruso in July 2010 and is headquartered in New York, NY. | Corporate Officer/Principal | 01/10/2020 |
R.F. Lafferty & Co., Inc.
R.F. Lafferty & Co., Inc. Investment Banks/BrokersFinance Founded in 1946, R.F. Lafferty & Co., Inc. is a brokerage firm and registered investment advisor located in New York City. The firm's research focuses on small- and mid-cap companies. | Corporate Officer/Principal | 01/06/2018 |
Laidlaw & Co. (UK) Ltd.
Laidlaw & Co. (UK) Ltd. Investment Banks/BrokersFinance Part of Laidlaw Holdings Ltd., Laidlaw & Co. (UK) Ltd. is a British company that provides investment advice. The private company is based in London, UK. The company was founded in 1842. Matthew D. Eitner has been the CEO of the company since 2010. | Corporate Officer/Principal | 01/04/2017 |
HUTN, INC. | Corporate Officer/Principal | - |
Formazione di Bryan Kobel
Franklin & Marshall College | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
HUTN, INC. | Finance |
TC BIOPHARM (HOLDINGS) PLC | Health Technology |
Aziende private | 5 |
---|---|
R.F. Lafferty & Co., Inc.
R.F. Lafferty & Co., Inc. Investment Banks/BrokersFinance Founded in 1946, R.F. Lafferty & Co., Inc. is a brokerage firm and registered investment advisor located in New York City. The firm's research focuses on small- and mid-cap companies. | Finance |
Laidlaw & Co. (UK) Ltd.
Laidlaw & Co. (UK) Ltd. Investment Banks/BrokersFinance Part of Laidlaw Holdings Ltd., Laidlaw & Co. (UK) Ltd. is a British company that provides investment advice. The private company is based in London, UK. The company was founded in 1842. Matthew D. Eitner has been the CEO of the company since 2010. | Finance |
The Alberleen Group LLC
The Alberleen Group LLC Investment Banks/BrokersFinance The Alberleen Group LLC provides investment banking services. The firm offers mergers, acquisitions advice, capital raising services, investment opportunities and merchant banking services. It serves to the energy, financials, healthcare, real estate industries. The company was founded by Jolyne Caruso in July 2010 and is headquartered in New York, NY. | Finance |
TCB Newco Ltd.
TCB Newco Ltd. Pharmaceuticals: MajorHealth Technology TCB Newco Ltd. provides clinical services. It develops CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease. The company was founded on July 5, 2021 and is headquartered in Motherwell, GB. | Health Technology |
TC BioPharm (North America), Inc. |
- Borsa valori
- Insiders
- Bryan Kobel